Gdowski, A.; Hayatshahi, H.; Fudala, R.; Joshi, R.; Liu, J.; Vishwanatha, J.K.; Jeyarajah, R.; Guzik, P.; Ranjan, A.P.
Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer. Pharmaceutics 2022, 14, 128.
https://doi.org/10.3390/pharmaceutics14010128
AMA Style
Gdowski A, Hayatshahi H, Fudala R, Joshi R, Liu J, Vishwanatha JK, Jeyarajah R, Guzik P, Ranjan AP.
Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer. Pharmaceutics. 2022; 14(1):128.
https://doi.org/10.3390/pharmaceutics14010128
Chicago/Turabian Style
Gdowski, Andrew, Hamed Hayatshahi, Rafal Fudala, Rohan Joshi, Jin Liu, Jamboor K. Vishwanatha, Rohan Jeyarajah, Paul Guzik, and Amalendu P. Ranjan.
2022. "Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer" Pharmaceutics 14, no. 1: 128.
https://doi.org/10.3390/pharmaceutics14010128
APA Style
Gdowski, A., Hayatshahi, H., Fudala, R., Joshi, R., Liu, J., Vishwanatha, J. K., Jeyarajah, R., Guzik, P., & Ranjan, A. P.
(2022). Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer. Pharmaceutics, 14(1), 128.
https://doi.org/10.3390/pharmaceutics14010128